Oeckl, PatrickPatrickOecklAnderl-Straub, SarahSarahAnderl-StraubVon Arnim, Christine A. F.Christine A. F.Von ArnimBaldeiras, InêsInêsBaldeirasDiehl-Schmid, JanineJanineDiehl-SchmidGrimmer, TimoTimoGrimmerHalbgebauer, SteffenSteffenHalbgebauerKort, Anna M.Anna M.KortLima, MarisaMarisaLimaMarques, Tainá M.Tainá M.MarquesOrtner, MarionMarionOrtnerSantana, IsabelIsabelSantanaSteinacker, PetraPetraSteinackerVerbeek, Marcel M.Marcel M.VerbeekVolk, Alexander E.Alexander E.VolkLudolph, Albert C.Albert C.LudolphOtto, MarkusMarkusOtto2022-05-022022-05-022022-04-27https://resolver.sub.uni-goettingen.de/purl?gro-2/107546Reactive astrogliosis is a hallmark of Alzheimer's disease (AD) and frontotemporal dementia (FTD) but differences between the diseases and time course are unclear. Here, we used serum levels of the astroglial marker glial fibrillary acidic protein (GFAP) to investigate differences in patients with AD dementia, mild cognitive impairment (MCI)-AD and behavioural variant FTD (bvFTD).enjournal_article10.1136/jnnp-2021-32854735477892